NRXBF (NurExone Biologic) Shares Buyback Ratio % : -46.15 (As of Mar. 22, 2025)

View and export this data going back to 2023. Start your Free Trial

What is NurExone Biologic Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. NurExone Biologic's current shares buyback ratio was -46.15%.

NurExone Biologic Shares Buyback Ratio % Historical Data

The historical data trend for NurExone Biologic's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic Shares Buyback Ratio % Chart

NurExone Biologic Annual Data

Trend

Dec21

Dec22

Dec23

Shares Buyback Ratio %

-1.11

-12.59

NurExone Biologic Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Shares Buyback Ratio %	Get a 7-Day Free Trial									-12.59	-	-36.40	-2.05	-5.00

NurExone Biologic Shares Buyback Ratio % Calculation

NurExone Biologic's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(42.855	-	48.250)	/	42.855
	=	-12.59%

NurExone Biologic's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2024 )	-	Shares Outstanding (EOP) (A: Sep. 2024 ))	/	Shares Outstanding (EOP) (A: Jun. 2024 )
	=	(67.162	-	70.517)	/	67.162
	=	-5.00%

NurExone Biologic Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

NurExone Biologic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (OTCPK:NRXBF) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

J90:Germany NRX:Canada

Address

1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9

Website

https://www.nurexone.com

NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.